BioTech Nation ... with Dr. Moira Gunn
Science:Life Sciences
This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations and risks. Dr. Ang emphasizes the potential of their treatment to revolutionize AML therapy and improve patient outcomes.
Getting Immune Systems to Recognize HER2+ tumors - Dr. Randy Schatzman, President & CEO, Bolt Biotherapeutics
22-45 Getting a Vaccination? What about a nasal spray?
23-04 Sir Rory Collins, Oxford Professor and Principal Investigator, UK Biobank
23-03 Dr. Rob Ross, CEO, Surface Oncology
Antidepressants Should Have Diagnostics???
23-01 Gene Kinney, President & CEO, Prothena Biosciences
22-52 Edward Humes, Pulitzer Prize Winner, "The Forever Witness"
22-51 Keven Ali, CEO, Organon
22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR Therapeutics
22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTx
22-48 Dr. Robert Ang, President & CEO, Vor Biopharma
22-47 Dr. James Mackay, President & CEO, Aristea Therapeutics
22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis Bio
22-16 Triple-Negative Breast Cancer is the most aggressive of all
Dr. George Yancopoulos, CEO, Regeneron
Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics
Mark Litton, President & CEO, Athira Pharma
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
COMPLEXITY
Speaking of Psychology